Warning: The NCBI web site requires JavaScript to function. more...
Clinical experience with the combined use of lopinavir/ritonavir and rifampicin.
L'homme RF, Nijland HM, Gras L, Aarnoutse RE, van Crevel R, Boeree M, Brinkman K, Prins JM, Juttmann JR, Burger DM.
AIDS. 2009 Apr 27;23(7):863-5.PMID: 19352137 [PubMed - indexed for MEDLINE]Related articles
High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets.
Nijland HM, L'homme RF, Rongen GA, van Uden P, van Crevel R, Boeree MJ, Aarnoutse RE, Koopmans PP, Burger DM.
AIDS. 2008 May 11;22(8):931-5.PMID: 18453852 [PubMed - indexed for MEDLINE]Related articles
Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients.
Ruslami R, Nijland HM, Alisjahbana B, Parwati I, van Crevel R, Aarnoutse RE.
Antimicrob Agents Chemother. 2007 Jul;51(7):2546-51. Epub 2007 Apr 23.PMID: 17452486 [PubMed - indexed for MEDLINE]Related articlesFree article
Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes.
Nijland HM, Ruslami R, Stalenhoef JE, Nelwan EJ, Alisjahbana B, Nelwan RH, van der Ven AJ, Danusantoso H, Aarnoutse RE, van Crevel R.
Clin Infect Dis. 2006 Oct 1;43(7):848-54. Epub 2006 Aug 22.PMID: 16941365 [PubMed - indexed for MEDLINE]Related articles
Evaluation of high- versus standard-dose rifampin in Indonesian patients with pulmonary tuberculosis.
Ruslami R, Nijland H, Aarnoutse R, Alisjahbana B, Soeroto AY, Ewalds S, van Crevel R.
Antimicrob Agents Chemother. 2006 Feb;50(2):822-3. No abstract available. PMID: 16436757 [PubMed - indexed for MEDLINE]Related articlesFree article
Filter your results:
Antimicrob Agents Chemother. 2007 Jul; 51(7):2546-51.
[Antimicrob Agents Chemother. 2007]
Antimicrob Agents Chemother. 2006 Feb; 50(2):822-3.
[Antimicrob Agents Chemother. 2006]
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on
» See more...